GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pulike Biological Engineering Inc (SHSE:603566) » Definitions » Cyclically Adjusted Price-to-FCF

Pulike Biological Engineering (SHSE:603566) Cyclically Adjusted Price-to-FCF : 69.25 (As of Sep. 22, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pulike Biological Engineering Cyclically Adjusted Price-to-FCF?

As of today (2024-09-22), Pulike Biological Engineering's current share price is ¥11.08. Pulike Biological Engineering's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 was ¥0.16. Pulike Biological Engineering's Cyclically Adjusted Price-to-FCF for today is 69.25.

The historical rank and industry rank for Pulike Biological Engineering's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SHSE:603566' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 67.08   Med: 110.94   Max: 161.84
Current: 67.08

During the past years, Pulike Biological Engineering's highest Cyclically Adjusted Price-to-FCF was 161.84. The lowest was 67.08. And the median was 110.94.

SHSE:603566's Cyclically Adjusted Price-to-FCF is ranked worse than
60.82% of 97 companies
in the Biotechnology industry
Industry Median: 44.84 vs SHSE:603566: 67.08

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Pulike Biological Engineering's adjusted free cash flow per share data for the three months ended in Jun. 2024 was ¥0.113. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥0.16 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pulike Biological Engineering Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Pulike Biological Engineering's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulike Biological Engineering Cyclically Adjusted Price-to-FCF Chart

Pulike Biological Engineering Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 120.47 115.70

Pulike Biological Engineering Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 134.07 112.39 115.70 96.81 83.12

Competitive Comparison of Pulike Biological Engineering's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Pulike Biological Engineering's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pulike Biological Engineering's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pulike Biological Engineering's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Pulike Biological Engineering's Cyclically Adjusted Price-to-FCF falls into.



Pulike Biological Engineering Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Pulike Biological Engineering's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=11.08/0.16
=69.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pulike Biological Engineering's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Pulike Biological Engineering's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0.113/114.7809*114.7809
=0.113

Current CPI (Jun. 2024) = 114.7809.

Pulike Biological Engineering Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201409 0.076 98.900 0.088
201412 0.342 99.000 0.397
201503 0.057 99.900 0.065
201506 0.261 99.500 0.301
201509 -0.197 100.500 -0.225
201512 0.218 100.600 0.249
201603 0.044 102.200 0.049
201606 0.078 101.400 0.088
201609 0.034 102.400 0.038
201612 0.404 102.600 0.452
201703 -0.081 103.200 -0.090
201706 0.061 103.100 0.068
201709 0.078 104.100 0.086
201712 0.206 104.500 0.226
201803 -0.087 105.300 -0.095
201806 0.147 104.900 0.161
201809 0.029 106.600 0.031
201812 0.138 106.500 0.149
201903 -0.183 107.700 -0.195
201906 0.084 107.700 0.090
201909 0.163 109.800 0.170
201912 0.135 111.200 0.139
202003 -0.078 112.300 -0.080
202006 0.044 110.400 0.046
202009 0.093 111.700 0.096
202012 0.212 111.500 0.218
202103 -0.157 112.662 -0.160
202106 -0.042 111.769 -0.043
202109 0.112 112.215 0.115
202112 -0.259 113.108 -0.263
202203 -0.232 114.335 -0.233
202206 0.083 114.558 0.083
202209 0.007 115.339 0.007
202212 -0.237 115.116 -0.236
202303 -0.271 115.116 -0.270
202306 -0.117 114.558 -0.117
202309 0.190 115.339 0.189
202312 0.118 114.781 0.118
202403 -0.192 115.227 -0.191
202406 0.113 114.781 0.113

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pulike Biological Engineering  (SHSE:603566) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Pulike Biological Engineering Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Pulike Biological Engineering's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulike Biological Engineering Business Description

Traded in Other Exchanges
N/A
Address
15th New governance, Henan Province, Luoyang, CHN, 471000
Pulike Biological Engineering Inc is engaged in the research and development and production and operation of veterinary drugs.
Executives
Sun Jin Zhong Director
Zhang Zhen Supervisors
Wang Zhu Yi Supervisors
Ma Sui Ying Director
Song Yong Jun Director
Hu Wei Director
Qiao Rong Cen senior management
Zhou Li Peng senior management
Tian Ke Gong senior management
Kang Du Li senior management
Zhao Rui senior management
Qin De Chao Director
Pei Lian Feng senior management
Zhang Li Chang Director
Zhang Xu Ke Director

Pulike Biological Engineering Headlines

No Headlines